Keeping Your Company’s Federal Contracting Options Safe in the Face of Pending BIOSECURE Act Legislation
FDA Law Blog: Biosimilars
MARCH 3, 2024
3558 ) on January 25, 2024. Effect on FDA approvals— In cases where a biological product or drug needs to change aspects of its manufacturing processes to avoid using a covered equipment or service, will it need to file supplements with FDA for the CMC update? House of Representatives ( H.B. 7085 ) and Senate ( S.B.
Let's personalize your content